title: Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging.
authors.affiliation: Department of Surgery, Breast Cancer Group, Institut Gustave Roussy, Villejuif, France. elisabeth.chereau@gmail.com
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Chéreau
authors.forename: Catherine
authors.initials: C
authors.lastname: Uzan
authors.forename: Corinne
authors.initials: C
authors.lastname: Balleyguier
authors.forename: Julie
authors.initials: J
authors.lastname: Chevalier
authors.forename: Brigitte Bressac
authors.initials: BB
authors.lastname: de Paillerets
authors.forename: Olivier
authors.initials: O
authors.lastname: Caron
authors.forename: Françoise
authors.initials: F
authors.lastname: Rimareix
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Mathieu
authors.forename: Martin
authors.initials: M
authors.lastname: Koskas
authors.forename: Céline
authors.initials: C
authors.lastname: Bourgier
authors.forename: Fabrice
authors.initials: F
authors.lastname: André
authors.forename: Clarisse
authors.initials: C
authors.lastname: Dromain
authors.forename: Suzette
authors.initials: S
authors.lastname: Delaloge
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006801:Humans; D053208:Kaplan-Meier Estimate; D008279:Magnetic Resonance Imaging; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D009154:Mutation; D011379:Prognosis; D011878:Radiotherapy; D021701:Sentinel Lymph Node Biopsy; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents